Patent: 6,472,179
✉ Email this page to a colleague
Summary for Patent: 6,472,179
Title: | Receptor based antagonists and methods of making and using |
Abstract: | The present invention provides a fusion polypeptide capable of binding a cytokine to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of making and uses for the fusion polypeptide. |
Inventor(s): | Stahl; Neil (Carmel, NY), Yancopoulos; George D. (Yorktown Heights, NY) |
Assignee: | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) |
Application Number: | 09/313,942 |
Patent Claims: | see list of patent claims |
Details for Patent 6,472,179
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST | rilonacept | For Injection | 125249 | February 27, 2008 | ⤷ Sign Up | 2018-09-25 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,472,179
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2005005638 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2004039951 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 0018932 | ⤷ Sign Up |
United States of America | 7927583 | ⤷ Sign Up |
United States of America | 7417134 | ⤷ Sign Up |
United States of America | 7361350 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |